Skip to content

Find our latest news, stories and press releases

Delivering long-term value for our stakeholders

Explore career opportunities and more

Impacting health for humanity

Listening...

Search Results

No Results

    Sorry, I don't understand. Please try again

    1. Home/
    2. Our company/
    3. Social impact /
    4. Global health equity /
    5. Enhancing the Efforts of Advocacy Organizations

    Enhancing the Efforts of Advocacy Organizations

    We work with partners globally to strengthen advocacy around disease prevention.

    Continuing the fight against HIV, Tuberculosis and Malaria

    This week is “UN Week” which marks the annual United Nations General Assembly meeting in New York. Top leaders from around the world have descended upon NY to discuss many pressing issues on the global agenda, including the SDG goals and improving health worldwide.

    Johnson & Johnson global public health supports World AIDS Day

    With an estimated 37 million people currently living with HIV globally and 2.1 million people becoming newly infected each year, Johnson & Johnson stands united with the global community to fight HIV and care for those infected, and impacted.

    Uniting for an HIV-free world infographic

    Learn how Johnson & Johnson is building on a 25-year legacy of commitment to end HIV through innovative partnerships and investments.

    Challenging innovators to make DREAMS come true

    In this Huffington Post blog, USAID Ambassador Deborah L. Birx, M.D., discusses how the DREAMS partnership aims to help combat HIV in adolescent girls and young women.

    DREAMS partners announce $85 million innovation challenge focused on solutions for reducing HIV infections

    Johnson & Johnson issued a call for innovative ideas to reduce HIV infections in adolescent girls and young women in 10 sub-Saharan African countries as part of the DREAMS Innovation Challenge, supported by PEPFAR.

    A road to hope: mothers2mothers

    mothers2mothers connects mentor mothers with women in communities who are living with HIV to empower them to keep themselves and their babies healthy.

    Save the Children partnership could help millions of children

    Johnson & Johnson announced a global partnership with Save the Children to support its core mission to improve newborn survival.

    Funding zika but but forgetting tuberculosis

    Additional support and funding is needed to help fight TB worldwide. Read more in this Health Affairs blog from Friends of the Global Fight Against AIDS, Tuberculosis and Malaria.

    The battle to end TB

    Learn how Johnson & Johnson employees “Unite to End TB” and bring new hope to those suffering from tuberculosis in Vietnam, South Africa and India.

    Antimicrobial resistance: A growing threat

    World Economic Forum, Davos, Switzerland. Addressing the emergence of superbugs and drug-resistant bacteria is critical to our economic future and global health.

    Call for new collective action to address antimicrobial resistance

    Johnson & Johnson announced it has joined more than 80 companies and organizations in signing the Declaration on Combating Antimicrobial Resistance, an industry-wide call to action that outlines how industry and governments can work together to support sustained innovation to address this growing problem.

    “Big Pharma” accelerates fight against “Superbugs”

    Bloomberg reports on the industry-wide partnership to accelerate the development of drugs and diagnostics to help fight antimicrobial resistance.

    Public-private partnership to combat tuberculosis

    Janssen and USAID entered into a new Memorandum of Understanding, as part of the U.S Government’s National Action Plan for combatting multi-drug resistant tuberculosis (MDR-TB), agreeing to expand patient access to novel MDR-TB therapies and increase funding for program partners.

    The preventable disease we all should be fighting against

    Johnson & Johnson leadership reflects on a trip to South Africa where they met Chandre Heaton, a young woman who overcame XDR-TB.

    Bolstering the world’s defense against antimicrobial resistance

    Janssen leaders urged consideration of a special framework for innovation in antibiotics research and development at a congressional hearing.

    United States General Assembly continues the fight against HIV, TB and Malaria

    Johnson & Johnson Vice President of Innovation, Global Public Health and Science Policy Communication, Seema Kumar shares her key highlights from the Global Fund Replenishment Conference to Fight HIV, Tuberculosis and Malaria.

    Davos 2016: Global public health and STEM education

    Learn more about key themes related to global public health and STEM education that emerged at the 2016 World Economic Forum in Davos, Switzerland.

    Our commitment to improving the health of women and children infographic

    Learn about Johnson & Johnson’s commitment to improve the health of women and children in five key areas.